Epeleuton-d5
Epeleuton-d5 (15 (S) -HEPE-d5 ethyl ester) is deuterium labeled Epeleuton. Epeleuton is a second-generation synthetic N-3 fatty acid derivative with activity in patients with non-alcoholic fatty liver disease, although it did not reach the primary endpoints of alanine aminotransferase and liver stiffness, but it can significantly reduce triglycerides, glycated hemoglobin, plasma glucose and inflammatory markers[1].
Product Specifications
Product Name Alternative
15 (S) -HEPE-d5 ethyl ester; 15 (S) -Hydoxy EPA-d5 ethyl ester; 15 (S) -Hydoxy eicosapetaeoic acid-d5 ethyl ester
UNSPSC
12352211
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Smiles
O[C@H](/C=C/C=C\C/C=C\C/C=C\CCCC(OCC)=O)C/C=C\C([2H])(C([2H])([2H])[2H])[2H]
Molecular Formula
C22H29D5O3
Molecular Weight
351.53
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SLC13A3 (Solute Carrier Family 13 (Sodium-Dependent Dicarboxylate Transporter), Member 3)
Research Grade Anti-Human EGFR/ERBB1/HER1 (HTI-1511)
Research Grade Anti-Human EGFR/ERBB1/HER1 (HTI-1511)
